(Q37282182)

19 August 2017

1 reference

title

Pen devices to improve patient adherence with insulin therapy in type 2 diabetes (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

1 reference

Henry Howard Goldstein

series ordinal

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

19 August 2017

published in

Postgraduate Medicine

1 reference

19 August 2017

volume

120

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

172-179

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

A systematic review of adherence with medications for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Challenges and strategies for moving patients to injectable medications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

A review of human and analogue insulin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Assessment of dose selection attributes with audible notification in insulin pen devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Functionality and acceptability of a new electronic insulin injection pen with a memory feature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

A comparison of insulin pen use in the United States and the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1917

21 January 2018

Identifiers

DOI

10.3810/PGM.2008.09.1917

1 reference

19 August 2017

1 reference